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Abstract
Inactivating variants in the centrosomal CEP78 gene have been found in cone‐rod
dystrophy with hearing loss (CRDHL), a particular phenotype distinct from Usher
syndrome. Here, we identified and functionally characterized the first CEP78
missense variant c.449T>C, p.(Leu150Ser) in three CRDHL families. The variant was
found in a biallelic state in two Belgian families and in a compound heterozygous
state—in trans with c.1462‐1G>T—in a third German family. Haplotype
reconstruction showed a founder effect. Homology modeling revealed a detrimental
effect of p.(Leu150Ser) on protein stability, which was corroborated in patients'
fibroblasts. Elongated primary cilia without clear ultrastructural abnormalities in
sperm or nasal brushes suggest impaired cilia assembly. Two affected males from
different families displayed sperm abnormalities causing infertility. One of these is a
heterozygous carrier of a complex allele in SPAG17, a ciliary gene previously
associated with autosomal recessive male infertility. Taken together, our data
indicate that a missense founder allele in CEP78 underlies the same sensorineural
CRDHL phenotype previously associated with inactivating variants. Interestingly,
the CEP78 phenotype has been possibly expanded with male infertility. Finally,
CEP78 loss‐of‐function variants may have an underestimated role in misdiagnosed
Usher syndrome, with or without sperm abnormalities.
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1 | INTRODUCTION
Inherited retinal diseases (IRDs) are a major cause of blindness
worldwide. They combine a group of genetic eye disorders with a
complex phenotypic spectrum caused by progressive degeneration of rod
and cone photoreceptors and/or the retinal pigment epithelium (Berger,
Kloeckener‐Gruissem, & Neidhardt, 2010). Tremendous genetic hetero-
geneity has been demonstrated by variants identified in over 270 genes
(RetNet—Retinal Information Network: https://sph.uth.edu/retnet;
Daiger et al., 1998), allowing a molecular diagnosis in up to 60% of cases
(Lee & Garg, 2015). A subset of IRDs, so‐called retinal ciliopathies, is
caused by mutations in genes involved in cilia biogenesis or function and
is usually associated with complex phenotypes (Hildebrandt, Benzing,
Katsanis, Schwartz, & Hildebrandt, 2011). Well‐described ciliopathies
including IRD are Usher syndrome (USH; MIM# 276900) and
Bardet‐Biedl syndrome (BBS; MIM# 209900), characterized by
multiorgan defects (Koenig, 2003). Due to their large clinical hetero-
geneity with overlapping features, the establishment of clinical diagnosis
for ciliopathies is often difficult, and in some cases, the phenotype results
from multiallelic defects (Reiter & Leroux, 2017; Shaheen et al., 2016).
Biallelic inactivating variants in CEP78, encoding the Centrosomal
Protein 78 (MIM# 617110), have been linked to autosomal recessive
cone‐rod dystrophy with hearing loss (CRDHL; MIM# 617236;
Namburi et al., 2016; Nikopoulos et al., 2016). The unique combination
of CRD and sensorineural hearing impairment was stated to be distinct
from the well‐known Usher syndrome, characterized by recessively
inherited retinitis pigmentosa (RP) and congenital mild to severe
hearing impairment or complete sensorineural deafness. Up to now,
seven different truncating mutations have been reported in CEP78,
segregating in CRDHL families of different origins (Fu et al., 2016;
Namburi et al., 2016; Nikopoulos et al., 2016). Furthermore, a
homozygous CEP78‐truncating variant was found in a family with
reported nonsyndromic RP (MIM# 268000; de Castro‐Miró et al.,
2016). So far, only frameshift and splice site variants have been
identified, with the latter all displaying exon skipping at the RNA level
(Fu et al., 2016; Namburi et al., 2016; Nikopoulos et al., 2016). In
addition, a homozygous deletion‐inversion‐deletion overlapping CEP78
has recently been described in a CRDHL case (Sanchis‐Juan et al.,
2018). Several functional studies at the protein level point to a
loss‐of‐function (LOF) effect with decreased amounts of protein,
correct subcellular localization, and importantly, elongated primary
cilia in patients' fibroblasts, a feature that has been observed in
other ciliopathies as well (Mokrzan, Lewis, & Mykytyn, 2007;
Nikopoulos et al., 2016).
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CEP78 (UniProt: Q5JTW2, 4 isoforms reported—www.uniprot.
org) is a component of the centrosome and localizes to the mature
centrioles (Brunk et al., 2016). The human full‐length protein of 722
amino acids (Q5JTW2‐2) contains an N‐terminal leucine‐rich repeat
(LRR) domain with five consecutive LRR domains, and a C‐terminal
coiled‐coil domain (Brunk et al., 2016; Hossain, Javadi Esfehani, Das,
& Tsang, 2017). Centrioles are the main components of centrosomes,
key microtubule‐organizing centers in eukaryotic cells, with the
mother centriole acting as the basal body during cilia formation
(Gönczy & Hatzopoulos, 2019). Centrioles duplicate only once per
cell cycle, and anomalies in their structure or number are associated
with several diseases including cancer and developmental disorders
such as ciliopathies (Gönczy, 2015; Nigg & Raff, 2009). Interestingly,
the dysregulation of CEP78 has already been associated with
prostate and colorectal cancers (Nesslinger et al., 2007; Zhang et al.,
2016). Recently, CEP78 has been suggested as a promising molecular
biomarker in thyroid carcinoma (Hammad et al., 2019).
Here, we functionally studied the first CEP78 missense variant,
which we identified in homozygous and compound heterozygous
states in three unrelated CRDHL families with and without male
infertility. We assessed other potential genetic causes underlying
male infertility, performed haplotype reconstruction for the missense
variant in the three families, evaluated protein modeling, and studied
induced cilia in patients' fibroblasts.
2 | MATERIALS AND METHODS
2.1 | Ethics statement
This study was conducted following the tenets of the Declaration of
Helsinki and ethical approval was given by the local ethics committee
(Ghent University Hospital, EC UZG 2017/1540; Lausanne
University Hospital, Protocol 09/14, Technical University Munich
4360/13). All individuals involved gave their informed consent before
inclusion in this study.
2.2 | Phenotypic evaluation
All affected individuals were subjected to a hearing assessment and
to detailed ophthalmologic evaluation including best‐corrected visual
acuity measurement, fundoscopy, visual field assessment, both
infrared and blue light reflectance and autofluorescence imaging,
spectral‐domain optical coherence tomography (SD‐OCT), and
electroretinography (ERG).
Because of a presumed syndromic ciliary phenotype, body mass
index (BMI) was calculated (family F1), the Sniffin' sticks smell test
(families F1 and F3) was used to estimate olfactory function and a
saccharin test to assess nasal mucociliary clearance (F1; Hummel,
Sekinger, Wolf, Pauli, & Kobal, 1997; Sherly & Prathibha, 2014). In
addition, semen evaluation was performed for the male probands
from F1 (subject III:2) and F2 (subject II:2) and F3 (subject II:1).
2.3 | Whole exome sequencing and variant
validation
Genomic DNA (gDNA) was extracted from leukocytes according to the
manufacturer's guidelines. Whole exome sequencing (WES) was
performed for two individuals from F1 (III:2 and III:5) using
SureSelectXT human All Exon V6 enrichment (Agilent) and NextSeq500
sequencing technology (Illumina). Read mapping and variant calling
were performed using the CLC Genomics Workbench (hg19 human
reference genome, v. 7.5.4, Qiagen). Duo exome sequencing was
performed for both affected individuals from family F3 (II:1 and II:2)
using SureSelectXT human All Exon V5 enrichment (Agilent) and
HighSeq2500 (Illumina) for sequencing. Reads were aligned to the
UCSC human reference assembly (hg19—https://genome.ucsc.edu)
with BWA (v.0.5.8). Single‐nucleotide variants and small insertions and
deletions were detected with SAMtools (v.0.1.7). Copy number
variations (CNVs) were detected with ExomeDepth (Plagnol et al.,
2012) and Pindel (Ye, Schulz, Long, Apweiler, & Ning, 2009).
Sanger sequencing of the coding exons and intron‐exon
boundaries of CEP78 (NM_001098802.2; F2, II:2) and SPAG17
(sperm associated antigen 17; NM_206996.2; MIM# 616554) was
performed using an ABI 3730xl DNA Analyzer (Applied Biosystems)
with the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems). Primer sequences are listed in Tables S1 and S2.
Human Genome Variation Society nomenclature (http://varnomen.
hgvs.org) was used for variant notation, with the A of the initiation codon
ATG as +1. The functional impact of identified sequence variants was
assessed trough in silico predictions in Alamut Visual (v.2.8.1), Alamut
Batch (v.1.9), and dbNSFP (v.3.4a), including missense prediction tools,
splice prediction tools, physicochemical distance (Grantham score),
evolutionary conservation, location in protein domains, presence in
dbSNP (build 151—https://www.ncbi.nlm.nih.gov/SNP), MetaDome
(https://stuart.radboudumc.nl/metadome/—v.1.0.1), Exome Variant
Server from the NHLBI Exome Sequencing Project (ESP—http://evs.gs.
washington.edu/EVS), ExAC (http://exac.broadinstitute.org/), and
gnomAD (http://gnomad.broadinstitute.org/; Liu, Wu, Li, & Boerwinkle,
2016; Wiel et al., 2019).
Multiplex polymerase chain reactions (PCRs) on the Y‐chromosome
(AZFa, AZFb, and AZFc) and for the SRY and USP9Y (DFFRY) genes were
performed to evaluate the presence of Y‐microdeletions in F1, III:2
(Krausz, Hoefsloot, Simoni, Tüttelmann, & European Academy of
Andrology, & European Molecular Genetics Quality Network, 2014).
2.4 | Haplotype analysis
In total, 11 microsatellite markers (Genome data viewer—https://
www.ncbi.nlm.nih.gov/genome/gdv) and 15 single‐nucleotide
polymorphisms (SNPs; dbSNP, build 151) were selected for
haplotype reconstruction in the area flanking CEP78. SNPs were
Sanger sequenced according to the standard procedures (see above).
For microsatellite fragment size determination, PCR products were
mixed with an internal GeneScan size standard (ROX‐500, Applied
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Biosystems) and Hi‐Di formamide (Applied Biosystems), and were
then loaded on the ABI 3730xl DNA Analyzer. Fragment sizes
were calculated using the GeneMapper software (v. 5.0, Applied
Biosystems). PCR primers were designed with Primer3Plus
(www.bioinformatics.nl/primer3plus) and sequences can be found in
Table S3 (Untergasser et al., 2007).
2.5 | CNV analysis for SPAG17
CNV analysis was performed for the SPAG17 gene by quantitative
PCR (qPCR). qPCR assays were designed per coding exon, as
previously described (D'haene, Vandesompele, & Hellemans, 2010).
Assays for each gDNA sample were prepared using the SsoAdvanced
Universal SYBR Green Supermix (Bio‐Rad Laboratories) and were
subsequently run in triplicate on a LightCycler 480 System (Roche).
Data were analyzed with qbase+ software (v. 3.1, Biogazelle). qPCR
primer design was done using Primer3Plus or PrimerXL, and ZNF80
and GPR15 were used as reference genes (Lefever et al., 2017;
Untergasser et al., 2007). Primer sequences can be found in Table S4.
2.6 | Homology modeling and FoldX calculations for
p.(Leu150Ser)
Amino acid residues 42‐199 of CEP78 were used as input sequences
for an HHPRED structure prediction (https://toolkit.tuebingen.mpg.
de/#/tools/hhpred; Söding, Biegert, & Lupas, 2005). Based on the
HHPRED output, structures with PDB code 5IRN, 1Z7X, and 1IO0
were chosen as best nonredundant templates for CEP78 modeling.
The corresponding HHPRED alignments of CEP78 with these
templates were used as input alignment for modeling of the CEP78
fragment using the YASARA structure homology modeling engine
(http://yasara.org/products.htm#structure; Krieger & Vriend, 2015).
The figure of the model was generated using UCSF chimera
(Pettersen et al., 2004). For FoldX mutant stability calculations on the
three models and on the three template structures, we used
the BuildModel command after structure optimization with the
RepairPDB command (Guerois, Nielsen, & Serrano, 2002).
2.7 | Immunoblotting on fibroblasts
Skin biopsies, taken from the inner aspect of the arm, were obtained
from patients with biallelic CEP78 variants (F1, III:2 and III:5; F3, II:1)
and heterozygous carriers (F1, II:2 and II:8). Starting from the skin
biopsy, a fibroblast culture was established in Dulbecco's minimal
essential medium (MEM) with phenol red (Life Technologies) supple-
mented with 10% fetal bovine serum (Labconsult), 1% kanamycin (Life
Technologies), 1% penicillin‐streptomycin (Life Technologies), and 1%
MEM nonessential amino acids (Life Technologies). To perform
immunoblotting of CEP78, total protein from cultured fibroblasts was
extracted with RIPA Buffer (Sigma‐Aldrich) from a full T75 flask. Lysis
buffer included protease inhibitory cocktail (Roche Diagnostics),
phosphatase inhibitory cocktail 2, and phosphatase inhibitory cocktail 3
(Sigma‐Aldrich). After centrifugation and reduction with 1M DTT
(Sigma‐Aldrich), protein lysates were subjected to sodium dodecyl
sulfate‐polyacrylamide gel electrophoresis (NuPAGE™ 4–12% Bis‐Tris
Protein Gels, ThermoFisher Scientific) with a ladder (Precision Plus
Protein All Blue Standards, Bio‐Rad Laboratories). Proteins were
transferred to a nitrocellulose membrane using the iBlot 2 Dry Blotting
System (Thermo Fisher Scientific). Membranes were blocked 2 hours
room temperature in 2% bovine serum albumin (BSA; Sigma‐Aldrich),
incubated with primary antibodies against CEP78, overnight at 4°C
(1:1000, A301‐800A, Bethyl) or β‐tubulin, 1 hour room temperature
(1:2500, ab6046, Abcam), and subsequently incubated with
horseradish‐peroxidase‐conjugated secondary antibody, 2 hours room
temperature (1:2500, 7074S, Cell Signaling Technologies). Membranes
were scanned with an Amersham Imager 680 system (GE Healthcare
Life Sciences), and CEP78 signal intensity quantitation was achieved
using ImageJ (NIH, v. 1.50i) and normalized to the amount of β‐tubulin.
Graphs display data points of three independent experiments and the
statistical analysis was performed in GraphPad (v. 5.04) using the Mann
–Whitney test.
2.8 | Immunocytochemistry on fibroblasts
Fibroblasts of controls and affected individuals and heterozygous
carriers of F1 were grown on glass chamber slides and starved in
serum‐free medium for 48 hr when confluent. Cells were fixed with
3.7% paraformaldehyde, permeabilized with 0.2% Triton X‐100,
blocked in 10% BSA in phosphate‐buffered saline, and incubated
overnight at 4°C with primary antibodies against TAPT1 (1:500,
Sigma, HPA042567) and α‐acetylated tubulin (1:1000, Sigma, T6793).
The TAPT1 antibody is marking the base of the cilium, whereas the
acetylated tubulin antibody is marking the ciliary axoneme (Symoens
et al., 2015). After washing, cells were incubated for 3 hr with
secondary antibodies at room temperature (1:750, Life Technologies,
donkey anti‐mouse Alexa Fluor 488 and donkey anti‐rabbit Alexa
Fluor 594) and mounted with coverslips (Vectashield Mounting
Medium with 4′,6‐diamidino‐2‐phenylindole). Images were captured
with a Zeiss AxioObserved‐Z1 microscope. Unbiased counting of at
least 100 events per sample (975 events in affected individuals, 405
in carriers, and 1,211 in controls) was performed. Cilia length was
measured using segmented lines in ImageJ and independently
evaluated by two investigators. The statistical analysis was
performed in GraphPad using one‐way ANOVA (Kruskal–Wallis test).
2.9 | Expression analysis and splicing assessment on
fibroblasts
For quantitative reverse‐transcription PCR (qRT‐PCR), total RNA was
extracted from cultured fibroblasts with the RNeasy Kit (Qiagen),
treated with RNase‐Free DNase (Qiagen), and complementary DNA
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(cDNA) was synthesized with the iScript cDNA Synthesis Kit (Bio‐Rad
Laboratories; CEP78) or the SuperScript VILO cDNA Synthesis Kit
(Invitrogen) (SPAG17). For each cDNA sample, assays were prepared
with the addition of SsoAdvanced Universal SYBR Green Supermix
(Bio‐Rad Laboratories) and were subsequently run in triplicate on a
Roche LightCycler 480 System. Data were analyzed with qbase+ (v. 3.1;
Biogazelle) and normalized to the HMBS, SDHA, and YWHAZ genes. For
nonquantitative RT‐PCR, cDNA underwent standard PCR and was then
loaded on the Fragment Analyzer 5300 (Agilent). No cycloheximide
(CHX) treatment has been performed before RNA extraction. Primers
were designed using Primer3plus or PrimerXL (http://www.primerxl.
org/) and sequences are listed in Table S5.
2.10 | Electron microscopy on nasal brush and
spermatids
Biopsies were obtained from the nasal (inferior turbinate) mucosa
of a homozygous individual (F1, III:2) and a heterozygous carrier
(F1, II:8). Spermatid electron microscopy (EM) pictures were
obtained from a semen sample from F2, II:2. Biopsies were immersed
in 2.5% glutaraldehyde and processed for ultrastructural analysis,
according to Shahana et al. (2005). Ultrathin sections were examined
at a final magnification of ×60,000 or ×85,000. In each specimen, an
analysis of at least 50 transverse ciliary sections of different cells was
required to study the internal axonemal structure. For the sperma-
tids, ultrathin sections of a gold interference color were cut using an
ultramicrotome (Leica EM UC6), followed by a poststaining in a Leica
EM AC20 for 40min in uranyl acetate at 20°C and for 10min in lead
stain at 20°C. Sections were collected on formvar‐coated copper slot
grids. Grids were viewed with a JEM 1400plus transmission electron
microscope (JEOL, Tokyo, Japan) operating at 80 kV. A qualitative
evaluation of general ciliary sections was performed as described
(Lucas, Paff, Goggin, & Haarman, 2016).
3 | RESULTS
3.1 | Clinical findings in individuals with CRDHL
from three families
The families included in this study are of Belgian (F1 and F2) and
German origin (F3). All patients included were clinically diagnosed
with CRDHL. Ophthalmic images and more detailed clinical features
are provided in Figure 1 and Table 1, respectively.
The ocular phenotype of the affected siblings in F1 has
previously been clinically described in part by us before the
identification of CEP78 as CRDHL disease gene (Witters, De Zaeytijd,
Leys, & Leroy, 2004). In F1, a syndromic phenotype was first
suspected due to the presence of several ciliopathy‐like character-
istics. BMI calculation showed obesity class II or III in affected
individuals and obesity class I or II in their parents (Table S6). Several
family members reported respiratory problems. However, smell and
saccharin tests showed only mild abnormalities (Table S7).
Importantly, the male proband of F1 (III:2) displays infertility,
which was supported by his semen evaluation showing oligoasthe-
noteratospermia (Table S8). In addition, diabetes type 2 has been
diagnosed for several members of F1 (II:8, III:2 and III:4) and a history
of colon cancer has been reported in the family branch of II:8 (three
out of four sisters).
The presence of male infertility in F1 prompted us to evaluate
male fertility in other families. Hence, we assessed the semen quality
of the male proband of F2 (II:2); however, no abnormalities were
observed (Table S8). Furthermore, there are no additional features
that support a syndromic ciliopathy in F2. Interestingly, additional
clinical features were found in F3: male infertility, more specifically
asthenoteratozoospermia in F3 (II:1; Table S8), and diabetes type 1 in
F3 (II:2). A smell test performed in these individuals did not show any
abnormalities (Table S7).
3.2 | Identification of the first CEP78 missense
variant in three CRDHL families
WES in two affected individuals of F1 (III:2 and III:5) revealed a
novel homozygous missense variant in CEP78, c.449T>C,
p.(Leu150Ser) (NM_001098802.1; Figures 2 and 3). In another
Belgian family with a CRDHL phenotype (F2, II:2), targeted analysis
of CEP78 revealed the same homozygous missense variant. WES in
two siblings from a third family with CRDHL (F3: II:1 and II:2)
showed presumed compound heterozygosity for p.(Leu150Ser) and
a novel splice site variant, c.1462‐1G>T. This substitution is located
in the acceptor splice site of intron 12 and is predicted to cause
skipping of exon 13, resulting in a frameshift. Aberrant splicing was
confirmed using RT‐PCR (Figure S1). The variants segregate with
disease in the three families proving the biallelic localization of the
identified variants (Figure 2a).
The missense variant changes an extremely conserved amino
acid position and is predicted to affect protein function according to
several in silico prediction tools (Figure S2 and Table S9). This change
is a known variant (rs761661253) and has an overall allele frequency
of 0.0000964 in ExAC and of 0.00004967 in gnomAD with no
homozygotes observed in both.
Haplotype analysis with 11 microsatellite markers and 15 SNPs
in F1 and F2 revealed a common haplotype of 1.7‐2.3Mb, which is
suggestive for a founder effect (Figure 2b, Table S10). One sibling of
F3 has been subsequently included in the haplotype reconstruction.
3.3 | Assessment of other potential genetic causes
of male infertility
The proband of F1 (III:2) suffers from male infertility (Table S8). To
assess a potential distinct genetic cause, we first evaluated the
occurrence of microdeletions of the Y chromosome, which was
negative (data not shown; Flannigan & Schlegel, 2017). Second, we
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assessed the presence of (likely) pathogenic variants in known and
candidate genes for male infertility in the WES data (Table S11).
From the filtered variants, two heterozygous variants were found in
the SPAG17 gene: c.4127del, p.(Pro1376LeufsTer8), and c.946G>T
p.(Ala316Ser) (NM_206996.2). Both variants are predicted to be
pathogenic (Table S11). Segregation analysis showed that the two
variants occur in cis and are maternal (F1, II:8; Figure 2a). Expression
analysis of SPAG17 messenger RNA (mRNA) in fibroblasts of the
heterozygous F1, II:8 showed decreased expression compared to
controls (Figure S3). This can likely be attributed to nonsense‐
mediated decay (NMD) resulting from the frameshift variant
c.4127del, p.(Pro1376LeufsTer8). So far, a homozygous missense
variant in SPAG17 c.4343G>A p.(Arg1448Gln) has been reported in
one patient from a consanguineous family, putting forward SPAG17
as candidate gene for recessive male infertility (Figure S4; Xu et al.,
2018). No second (likely) pathogenic SPAG17 variant could be
identified however in F1 (III:2) by sequencing of all exons that had
coverage below 20x in the WES data, by sequencing of the
untranslated regions (UTRs) and by CNV analysis of all exons (data
not shown). Deep intronic variants or noncoding variants in
regulatory regions cannot be excluded by this assessment.
As the proband of F3 (II:1) displays male infertility as well, his
WES data were revisited, but no (likely) pathogenic variants were
identified. No Y‐deletion test was available for F3 (II:1).
3.4 | Homology modeling and FoldX calculations of
p.(Leu150Ser)
The N‐terminal domain of CEP78 is predicted to contain multiple
LRRs, some of which have been shown to be involved in protein–
protein interactions (Matsushima et al., 2005). Leu150 is the first
leucine residue of an LRR and the LRR seems to fit the consensus
sequence of RNAse inhibitor‐like (RI‐like) class leucine rich repeats
F IGURE 1 Representative ophthalmological pictures of individuals carrying c.449T>C p.(Leu150Ser) in CEP78 (F1, III:2 and III:5). Clockwise
from top left: (a) Composite fundus image of OD of male patient aged 53 (III:2). Severe reduction in vascular caliber, small white dots from the
macula up to the midperiphery, relatively better preservation of fovea as well as peripheral retina, and spicular intraretinal pigmentation in
nasal midperiphery. (b) Composite fundus picture of OS of female patient aged 47 (III:5). Virtually normal fundus except for mild reduction in
vascular caliber. Abnormality of superonasal vessels to optic disc is composite artifact. (c) Blue light autofluorescence image of OS of III:5.
Diffuse, mottled hyperautofluorescence is more pronounced in circle around central macula. (d) SD‐OCT of central macula of OS of III:5.
Thinning of foveal area with considerable loss of definition of outer retinal layers (RPE and PRs). (e) SD‐OCT of central macula of OD of III:2.
Thinning of outer retinal layers representing RPE and PRs, which are relatively better preserved in foveal area. Other retinal layers seem rather
disorganized in the temporal macula. OD, oculus dexter (right eye); OS, oculus sinister (left eye); SD‐OCT, spectral‐domain optical coherence
tomography; PR, photoreceptor; RPE, retinal pigment epithelium
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(Matsushima et al., 2005). Variants of the first leucine to proline,
phenylalanine, or histidine in the repeats of four other LRR proteins
have been found to be disruptive and to underlie different diseases,
including congenital stationary night blindness (NYX; MIM# 300278),
hereditary bleeding disorder (GP1BA; MIM# 606672), and
immunodysregulation (CARMIL2; MIM# 610859; Matsushima et al.,
2005; Sorte et al., 2016). We used homology modeling and FoldX
calculations to predict whether the p.(Leu150Ser) variant can
similarly affect the structure or stability of CEP78.
HHPRED searches confirmed that LRR containing structures are
the best templates for homology modeling of the CEP78 N‐terminal
region (Söding et al., 2005). In the alignments, Leu150 indeed aligns
with the first leucine of an LRR of the templates. We used the best
three HHPRED hits as template for modeling of the CEP78
N‐terminal region: NOD2 (PDB code: 5IRN), Tropomodulin C20
domain (PDB code: 1IO0), and RNAse inhibitor (PDB code: 1Z7X,
chain W). All these structures have RI class LRRs. Three separate
models were built based on these three templates.
The model based on the RNAse inhibitor (PDB code1Z7X) template
can be seen in Figure 4a. A very similar arrangement is found in both
other models. Leu150 is packed between six other leucine residues in
the hydrophobic core of the LRR fold, and replacing Leu150 to serine
disturbs this packing and introduces a serine in a very hydrophobic
environment. This is most likely detrimental for the protein folding. We
used FoldX to predict the effect of p.(Leu150Ser) on protein stability in
the three models (Guerois et al., 2002). The variant is predicted to have
a very destabilizing effect, with a ΔΔG of >4.5 kcal/mol in FoldX for all
three models. Similarly, mutation of the aligning leucine residue to
serine in the three template structures (5IRN: L965; 1IO0: L282; 1Z7X:
L371) is predicted to have a very disruptive effect with a ΔΔG of
>4.5 kcal/mol in FoldX for all three structures. This suggests that the
p.(Leu150Ser) variant in CEP78, and similar variants of the first leucine
to serine in other LRR proteins, severely affect protein stability.
3.5 | Missense variant p.(Leu150Ser) causes
decreased CEP78 protein levels in patients'
fibroblasts
Since the result of the homology protein modeling is indicating a
strong effect of p.(Leu150Ser) on protein stability, immunoblot of
CEP78 was performed using fibroblast protein extracts from a
homozygous (F1, III:5) and compound heterozygous patient (F3, II:1),
from two p.(Leu150Ser) heterozygous carriers (F1, II:2 and II:8), and
from two unrelated controls. Compared to controls, the amount of
CEP78 is significantly reduced in heterozygous carriers (p = .0075)
and nearly undetectable in homozygous/compound heterozygous
patients (p = .0048; Figures 4b,c, S5, and S6). Subsequent mRNA
expression analysis of CEP78 showed no decreased expression in
homozygous individual F1, III:5, confirming that the effect of the
variant is probably restricted to the protein level. Compound
heterozygous individual F3, II:1 shows only a subtly decreased CEP78
expression that can be attributed to the splicing variant (Figure S7).T
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3.6 | Ciliary assessment in patients' fibroblasts,
nasal brush, and sperm
Biallelic truncating variants in CEP78 have previously been
associated with elongated primary cilia (Nikopoulos et al., 2016). To
evaluate the ciliary length in individuals biallelic or monoallelic for
p.(Leu150Ser), immunostaining against α‐acetylated tubulin and
TAPT1 was performed on fibroblast cultures. Subsequent cilia length
assessment in members of F1 revealed that induced primary cilia are
significantly longer in fibroblasts from homozygous and heterozygous
individuals than in those from control cells (p < 1.0 x 10−4; Figures 5a
and S8 and Table S12).
F IGURE 2 Pedigrees segregating the CEP78 and SPAG17 variants, and haplotype reconstruction for the c.449T>C/p.(Leu150Ser) variant in
CEP78. (a) F3, II:1 and II:2 are compound heterozygous for c.[449T>C]; [1462‐1G>T] p.[Leu150Ser];[?]. In F1, two variants p.(Pro1376LeufsTer8)
and p.(Ala316Ser) were identified in SPAG17, occurring however in cis. (b) Haplotype reconstruction highlighted p.(Leu150Ser) in CEP78 as a
founder allele. Complete haplotype is available in Table S10. M, mutant allele; +, wild‐type allele
F IGURE 3 Location of known CEP78 variants. Schematic diagram of the CEP78 protein showing the location of the previously described
truncating variants and the novel variants reported in this study (in bold). The previously published variant causing RP is indicated with a dashed
line. CEP78 includes multiple leucine‐rich repeats (LRR, in gray) located at the N‐terminal, and a coiled‐coil domain at the C‐terminal (in black).
The missense change described in this study is located in one of the LRRs. The splice site substitution is predicted to cause skipping of exon 13.
This figure has been adapted from material from Brunk et al. (2016). RP, retinitis pigmentosa
1006 | ASCARI ET AL.
Transmission EM of cross sections of ciliated nasal epithelium cells
showed the conventional “9 + 2” microtubule doublet configuration
with the presence of dynein arms in both a homozygous individual (F1,
III:2) and a heterozygous carrier (F1, II:8) (Figure 5b). Transmission EM
was also performed on a sperm sample obtained from F2, II:2, but no
relevant anomalies of the main structures were identified (Figure S9).
Overall, no clear ultrastructural abnormalities of cilia were observed
both in nasal brush and sperm.
4 | DISCUSSION
Several studies have linked CEP78‐truncating variants with a unique
CRDHL phenotype and, so far, all described variants are frameshift
or splice site sequence variants with a presumed LOF effect.
Recently, a homozygous structural variant affecting CEP78, that is, a
deletion‐inversion‐deletion, has also been described in a patient
with CRDHL (Table S13; Fu et al., 2016; Namburi et al., 2016;
F IGURE 4 (a) Structural modeling of the p.(Leu150Ser) CEP78 missense variant. Residues 106‐184 of the model of CEP78 N‐terminal
domain (V42‐K198) based on an RNAse inhibitor structure were used as a template. In this model, Leu150 (L150, green) is surrounded by six
other leucine residues (indicated with arrows). (b) Immunoblotting of endogenous CEP78 in primary fibroblasts. Since the p.(Leu150Ser) change
is predicted to affect protein stability, protein levels of CEP78 were evaluated in available primary fibroblasts of F1 (II:2, II:8 and III:5) and F3
(II:1). Undetectable protein or strongly reduced CEP78 levels has been detected in the homozygous/compound heterozygous and heterozygous
individuals, respectively. (c) Relative amounts of CEP78 were calculated on three independent western blots. Compared to controls, the amount
of CEP78 is reduced in heterozygous carriers (p = .0075) and nearly undetectable in homozygous/compound heterozygous patients (p = .0048).
M, mutation (in black: c.1462‐1G>T; in red: c.449T>C); +, wild type
F IGURE 5 (a) Analysis of ciliary length. Fibroblasts from homozygous (F1, III:2 and III:5) and heterozygous (F1, II:2 and II:8) individuals show
significantly longer primary cilia than those from unaffected control individuals (p < .001). (b) EM cilia. Ciliary ultrastructure from nasal brush
samples obtained from one affected individual (F1, III:2) and one heterozygous carrier (F1, II:8), presents the conventional 9 + 2 microtubule
doublet configuration. Scale bars 100 or 500 nm. EM, electron microscopy
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Nikopoulos et al., 2016; Sanchis‐Juan et al., 2018; de Castro‐Miró
et al., 2016). Here, we report the first missense variant causing
CRDHL, c.449T>C, p.(Leu150Ser), expanding the CEP78 molecular
spectrum. The founder effect of the variant identified in three
unrelated families of Belgian and German origin may indicate a
potentially higher prevalence of this variant in other cases of
Northwestern origin with a recognizable CRDHL phenotype. Indeed,
based on a clinical diagnosis of CRDHL, targeted testing of CEP78 has
revealed this pathogenic variant in F2, II:2.
Other features that may advance the differential diagnosis
between the CRDHL phenotype and Usher syndrome are
extra‐sensorial, syndromic symptoms such as male infertility (F1
and F3). To assess if other causes for male infertility are present in
F1 and F3, WES data of F1, III:2 and F3, II:1 were filtered for variants
in reported male infertility genes (Table S11). This revealed two
novel heterozygous variants in SPAG17 in F1, III:2, which proved to
occur in cis. A decreased expression of SPAG17 could be shown in
fibroblasts of F1, II:8. No additional (likely) pathogenic variants could
be found in the male infertility gene panel and so far only one
homozygous missense variant has been reported in two twin broth-
ers from a consanguineous family with severe asthenozoospermia
(Xu et al., 2018). In parallel, homozygous variants in SPAG17 and
WDR35 were described in a patient with multiple brain and skeletal
anomalies, with a presumed combinatorial effect on the ciliary
phenotype (Córdova‐Fletes et al., 2018). Furthermore, a SPAG17
missense variant has been associated with primary ciliary dyskinesia
(Andjelkovic et al., 2018). SPAG17 encodes a protein present in the
axoneme central pair complex of motile cilia and flagella (Goduti &
Smith, 2012; Mitchell & Smith, 2009). Conditional knockout mouse
models support a critical role for SPAG17 in the function and
structure of cilia, showing that SPAG17 is essential not only for
sperm motility but also for normal manchette structure, protein
transport, and formation of the sperm head and flagellum (Kazarian
et al., 2018; Teves et al., 2015, 2013). Despite the role of SPAG17 in
sperm biology and its previous potential disease associations, the role
of the SPAG17 complex allele in the pathogenesis of the male
infertility of F1, III:2 is currently unclear. Given the co‐occurrence of
male infertility in two affected individuals (F1, III:2 and F3, II:1) of
two unrelated families and the absence of other (likely) pathogenic
variants in male infertility genes in both cases, we can speculate
about a primary role of the CEP78 genotype in the pathogenesis of
the male infertility in F1 and F3.
Apart from the genetic data, this study provides other lines of
evidence that support the pathogenicity of p.(Leu150Ser). First, amino
acid conservation and in silico predictions indicate a disease‐causing
effect. Next, homology modeling and FoldX calculation for this sub-
stitution in the CEP78 protein model point to a detrimental effect
on protein folding and stability due to an amino acid change in an
extremely conserved domain, probably involved in protein–protein
interactions (Matsushima et al., 2005). Subsequently, expression studies
on patient material showed a reduced expression restricted to the
protein level and correlated with the zygosity of the missense variant.
In the compound heterozygous individual, a subtly decreased mRNA
expression level was observed while a clearly lower protein level was
seen, which can likely be attributed to NMD caused by the novel splice
site variant. Overall, the strong predicted effect of the missense variant
on protein stability is suggestive for an LOF mechanism, similar to the
already described CEP78 variants.
The ciliary consequences of the missense variant are
recapitulating the effect already described for truncating CEP78
variants and for other proteins involved in ciliogenesis (Nikopoulos
et al., 2016; Wang et al., 2013). Specifically, we reported elongated
primary cilia in affected fibroblasts, that is, a difference of ~1 μm
between patient and control cells, which is comparable with what has
been reported by Nikopoulos et al. (2016). No clear ultrastructural
defects could be demonstrated in nasal brushes and semen sample
however. Remarkably, heterozygous carriers of the missense variant
displayed an intermediate cellular phenotype, a feature that has
already been described both in ciliary and nonciliary contexts (Fog
et al., 2018; Noone et al., 2004). Downstream analysis of the Sonic
Hedgehog (SHH) signaling pathway was not informative under the
given experimental setup (data not shown). Phenotypes typically
associated with defective SHH signaling, such as polydactyly and
central nervous system developmental anomalies, were not observed
however (Reiter & Leroux, 2017).
CEP78 has been described as an interactor of polo‐like kinase 4
(PLK4) where colocalization of CEP78 and PLK4 is required for
PLK4‐mediated centriole overduplication (Brunk et al., 2016). PLK4
is the major serine/threonine kinase in centrioles and recent
evidence pointed out that PLK4‐mediated phosphorylation of
CCP110 (often called CP110), a well‐described regulator of
ciliogenesis, is an essential step for centriole assembly (Habedanck,
Stierhof, Wilkinson, & Nigg, 2005; Kleylein‐Sohn et al., 2007; M. Lee,
Seo, Chang, Hwang, & Rhee, 2017). Interestingly, CEP78 directly
interacts with viral protein R binding protein (DCAF1, also known as
VPRBP), a component of an E3 ubiquitin ligase, and restrains the
transfer of ubiquitin from the complex to CCP110, thus influencing
the cellular processes mediated by CCP110, an endogenous inhibitor
of ciliogenesis (Figure S10; Hossain et al., 2017). A more recent study,
in the context of HIV‐1 infection, reinforced the idea that CEP78
counterbalances the effects of VPRBP on CCP110 (Hossain, Ferreira
Barbosa, Cohen, & Tsang, 2018). Although the exact mechanism
needs to be proven, it is tempting to speculate about dysregulated
processes controlled by CCP110, cilia elongation processes in primis,
as a result from a lower amount of CEP78 protein (Schmidt et al.,
2009; Walentek et al., 2016).
In conclusion, we found the first CEP78 missense variant
to underlie the same sensorial CRDHL phenotype as previously
associated with inactivating variants, expanding the molecular
spectrum. Due to a founder effect, we may anticipate a higher
prevalence in other cases of Northwestern origin with a recogniz-
able CRDHL phenotype. Apart from the sensorial phenotype, we
reported male infertility in CEP78 missense cases. Finally, CEP78
LOF variants may have an underestimated role in the pathogenesis
of atypical or misdiagnosed Usher syndrome with or without sperm
abnormalities.
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